Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs

David Henry*, Paulina Stehlik, Laura Rosella

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

2 Citations (Scopus)


Brophy and Bally have expressed several concerns about our commentary1 regarding their meta-analysis of observational studies of the use of non-steroidal anti-inflammatory drugs (NSAIDs) and myocardial infarction, published in the BMJ.2 We are grateful for the opportunity to respond to these concerns.
Original languageEnglish
Pages (from-to)675-676
Number of pages2
JournalInternational Journal of Epidemiology
Issue number2
Publication statusPublished - 30 Mar 2018

Cite this